$ZSPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZS Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ZS Pharma, Inc.. Get notifications about new insider transactions in ZS Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | DEVON PARK BIOVENTURES LP | 10% Owner | Sell | U | 90.00 | 2,576,724 | 231,905,160 | 0 | 2.6 M to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | DEVON PARK BIOVENTURES LP | 10% Owner | Sell | U | 90.00 | 9,748 | 877,320 | 0 | 9.7 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 55.57 | 15,076 | 837,773 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 27.16 | 31,637 | 859,261 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 27.16 | 1,820 | 49,431 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 10.92 | 32,090 | 350,558 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 10.92 | 23,457 | 256,249 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 2.13 | 97,489 | 207,496 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 2.13 | 116,987 | 248,995 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Option Exercise | D | 1.03 | 77,991 | 79,995 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | Chief Medical Offic ... | Sell | D | 90.00 | 3,000 | 270,000 | 0 | 3 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Option Exercise | D | 32.56 | 12,000 | 390,720 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Babler Martin | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Babler Martin | Director | Option Exercise | D | 46.86 | 12,000 | 562,320 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Babler Martin | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Option Exercise | D | 32.56 | 12,000 | 390,720 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | D | 56.31 | 77,900 | 4,386,549 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Farrow Jeffrey S | Chief Financial Off ... | Option Exercise | D | 56.31 | 7,100 | 399,801 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Popovits Kimberly J | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Popovits Kimberly J | Director | Option Exercise | D | 39.01 | 12,000 | 468,120 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Popovits Kimberly J | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 55.57 | 15,158 | 842,330 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 55.57 | 1,717 | 95,414 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 46.00 | 4,675 | 215,050 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 46.00 | 99 | 4,554 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 27.16 | 22,125 | 600,915 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 27.16 | 4,095 | 111,220 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 10.92 | 17,279 | 188,759 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 10.92 | 3,190 | 34,848 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | D | 2.13 | 155,983 | 331,994 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Sell | D | 90.00 | 12,599 | 1,133,910 | 0 | 12.6 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 55.57 | 15,076 | 837,773 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 27.16 | 30,246 | 821,481 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 27.16 | 2,791 | 75,804 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 10.92 | 20,520 | 224,165 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 10.92 | 5,504 | 60,127 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 2.13 | 185,230 | 394,244 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Sell | D | 90.00 | 12,598 | 1,133,820 | 0 | 12.6 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Option Exercise | D | 32.56 | 12,000 | 390,720 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Option Exercise | D | 28.75 | 15,076 | 433,435 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Option Exercise | D | 28.75 | 71,088 | 2,043,780 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Option Exercise | D | 28.75 | 10,434 | 299,978 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Sell | D | 90.00 | 6,921 | 622,890 | 0 | 6.9 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 55.57 | 35,701 | 1,983,905 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 27.16 | 32,086 | 871,456 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 27.16 | 951 | 25,829 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 10.92 | 25,096 | 274,154 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 10.92 | 47,219 | 515,830 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 2.13 | 155,983 | 331,994 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 2.13 | 185,230 | 394,244 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 2.56 | 50,694 | 130,000 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | D | 1.03 | 37,046 | 37,998 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Sell | U | 90.00 | 186,923 | 16,823,070 | 0 | 186.9 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Sell | D | 90.00 | 15,654 | 1,408,860 | 0 | 15.7 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 55.57 | 15,076 | 837,773 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 27.16 | 1,150 | 31,234 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 27.16 | 31,887 | 866,051 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 10.92 | 24,603 | 268,768 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 10.92 | 41,788 | 456,500 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 2.13 | 136,485 | 290,495 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 2.13 | 175,481 | 373,494 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 2.56 | 50,694 | 130,000 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | D | 1.03 | 35,096 | 35,998 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Sell | U | 90.00 | 216,169 | 19,455,210 | 0 | 216.2 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Sell | D | 90.00 | 12,353 | 1,111,770 | 0 | 12.4 K to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Option Exercise | D | 55.57 | 4,000 | 222,280 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Option Exercise | D | 32.56 | 12,000 | 390,720 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Sell | D | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 55.57 | 73,201 | 4,067,780 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 27.16 | 74,748 | 2,030,156 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 27.16 | 2,864 | 77,786 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 5.62 | 132,473 | 743,968 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 5.62 | 39,566 | 222,203 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 2.13 | 448,453 | 954,487 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Sell | D | 90.00 | 30,750 | 2,767,500 | 0 | 30.8 K to 0 (-100.00 %) |
Dec 11 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | M | 10.92 | 9,154 | 100,000 | 24,603 | |
Dec 11 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Buy | M | 10.92 | 9,154 | 100,000 | 225,323 | 216.2 K to 225.3 K (+4.23 %) |
Dec 11 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | M | 10.92 | 9,154 | 100,000 | 25,096 | |
Dec 11 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Buy | M | 10.92 | 9,154 | 100,000 | 196,077 | 186.9 K to 196.1 K (+4.90 %) |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | M | 10.92 | 9,155 | 100,011 | 20,520 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Buy | M | 10.92 | 9,155 | 100,011 | 9,155 | 0 to 9.2 K |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 5.62 | 17,807 | 100,004 | 39,566 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 5.62 | 17,807 | 100,004 | 17,807 | 0 to 17.8 K |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | M | 10.92 | 9,156 | 100,022 | 17,279 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Buy | M | 10.92 | 9,156 | 100,022 | 9,156 | 0 to 9.2 K |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Option Exercise | M | 28.75 | 3,478 | 99,993 | 10,434 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | Chief Legal Officer | Buy | M | 28.75 | 3,478 | 99,993 | 3,478 | 0 to 3.5 K |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Option Exercise | M | 2.13 | 50,000 | 106,500 | 210,771 | ||
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Option Exercise | M | 2.13 | 20,000 | 42,600 | 260,771 | ||
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Sell | S | 49.76 | 50,000 | 2,488,000 | 0 | 50 K to 0 (-100.00 %) | |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Buy | M | 2.13 | 50,000 | 106,500 | 50,000 | 0 to 50 K | |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Sell | S | 50.03 | 20,000 | 1,000,600 | 0 | 20 K to 0 (-100.00 %) | |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Buy | M | 2.13 | 20,000 | 42,600 | 20,000 | 0 to 20 K | |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Aug 24 2015 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 29 2015 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 29 2015 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Popovits Kimberly J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Babler Martin | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Babler Martin | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | See Remarks | Option Exercise | A | 0.00 | 6,500 | 0 | 6,500 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | See Remarks | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | RASMUSSEN HENRIK S MD | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Tomasi Adam | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | See Remarks | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | See Remarks | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Asbury Mark | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jun 09 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 57.53 | 11,200 | 644,336 | 2,646,643 | 2.7 M to 2.6 M (-0.42 %) |
Jun 09 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 57.88 | 164,227 | 9,505,459 | 2,657,843 | 2.8 M to 2.7 M (-5.82 %) |
Jun 05 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 57.71 | 48,913 | 2,822,769 | 2,822,070 | 2.9 M to 2.8 M (-1.70 %) |
Jun 05 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 57.21 | 39,495 | 2,259,509 | 2,870,983 | 2.9 M to 2.9 M (-1.36 %) |
Jun 05 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 56.60 | 23,189 | 1,312,497 | 2,910,478 | 2.9 M to 2.9 M (-0.79 %) |
Jun 02 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 56.77 | 84,342 | 4,788,095 | 2,933,667 | 3 M to 2.9 M (-2.79 %) |
Jun 02 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 58.00 | 72,520 | 4,206,160 | 3,018,009 | 3.1 M to 3 M (-2.35 %) |
Jun 02 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 59.69 | 14,696 | 877,204 | 3,090,529 | 3.1 M to 3.1 M (-0.47 %) |
Jun 02 2015 | ZSPH | ZS Pharma, Inc. | Alta Partners VIII, L.P. | 10% Owner | Sell | S | 58.63 | 124,865 | 7,320,835 | 3,105,225 | 3.2 M to 3.1 M (-3.87 %) |
Dec 17 2014 | ZSPH | ZS Pharma, Inc. | 3x5 Special Opportunity Fund, ... | 10% Owner | Sell | S | 47.09 | 79,444 | 3,741,336 | 123,247 | 202.7 K to 123.2 K (-39.19 %) |
Dec 17 2014 | ZSPH | ZS Pharma, Inc. | 3x5 Special Opportunity Fund, ... | 10% Owner | Sell | J | 0.00 | 365,354 | 0 | 1,621,938 | 2 M to 1.6 M (-18.38 %) |
Aug 26 2014 | ZSPH | ZS Pharma, Inc. | NOHRA GUY P | Director | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Aug 26 2014 | ZSPH | ZS Pharma, Inc. | WHITING JOHN M | Director | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Aug 26 2014 | ZSPH | ZS Pharma, Inc. | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Aug 26 2014 | ZSPH | ZS Pharma, Inc. | OSTRO MARC | Director | Option Exercise | A | 32.56 | 12,000 | 390,720 | 12,000 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | Creech Todd A | Chief Financial Off ... | Option Exercise | A | 0.00 | 38,910 | 0 | 38,910 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | A | 0.00 | 77,612 | 0 | 77,612 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | KEYSER D JEFFREY | Chief Operating Off ... | Option Exercise | A | 0.00 | 33,037 | 0 | 33,037 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | Guillem Alvaro | President | Option Exercise | A | 0.00 | 33,037 | 0 | 33,037 |